Emergent BioSolutions Inc.
EBS
$5.63
-$0.25-4.25%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 149.10M | 99.50M | 149.90M | 69.70M | 78.50M |
| Total Receivables | 203.70M | 154.50M | 121.30M | 196.30M | 233.50M |
| Inventory | 314.00M | 311.70M | 322.70M | 317.50M | 333.40M |
| Prepaid Expenses | 30.20M | 26.90M | 61.00M | 36.00M | 36.50M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 9.80M | 6.10M | 6.50M | 35.00M | 500.00K |
| Total Current Assets | 706.80M | 598.70M | 661.40M | 654.50M | 682.40M |
|
|
|||||
| Total Current Assets | 706.80M | 598.70M | 661.40M | 654.50M | 682.40M |
| Net Property, Plant & Equipment | 227.60M | 282.30M | 290.50M | 319.90M | 394.70M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 485.20M | 501.50M | 517.80M | 534.10M | 550.40M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.50M | 7.20M | 8.10M | 5.00M | 176.10M |
| Total Assets | 1.43B | 1.39B | 1.48B | 1.51B | 1.80B |
|
|
|||||
| Total Accounts Payable | 58.10M | 60.90M | 82.10M | 95.90M | 100.20M |
| Total Accrued Expenses | 37.90M | 73.80M | 79.40M | 83.90M | 56.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.90M | 2.70M | 3.50M | 418.30M | 462.50M |
| Total Finance Division Other Current Liabilities | 14.00M | 25.00M | 64.90M | 21.60M | 11.20M |
| Total Other Current Liabilities | 14.00M | 25.00M | 64.90M | 21.60M | 11.20M |
| Total Current Liabilities | 111.90M | 162.40M | 229.90M | 619.70M | 630.20M |
|
|
|||||
| Total Current Liabilities | 111.90M | 162.40M | 229.90M | 619.70M | 630.20M |
| Long-Term Debt | 665.70M | 663.70M | 661.80M | 447.00M | 446.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.10M | 9.70M | 10.70M | 11.50M | 13.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 90.70M | 71.10M | 67.00M | 49.00M | 49.80M |
| Total Liabilities | 873.40M | 906.90M | 969.40M | 1.13B | 1.14B |
|
|
|||||
| Common Stock & APIC | 930.90M | 928.10M | 924.50M | 915.40M | 909.90M |
| Retained Earnings | -144.40M | -212.40M | -181.10M | -295.90M | -12.80M |
| Treasury Stock & Other | -233.80M | -232.90M | -235.00M | -233.20M | -233.20M |
| Total Common Equity | 552.70M | 482.80M | 508.40M | 386.30M | 663.90M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 552.70M | 482.80M | 508.40M | 386.30M | 663.90M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 552.70M | 482.80M | 508.40M | 386.30M | 663.90M |
|
|
|||||